Vikhyat Bebarta
Concepts (643)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antidotes | 38 | 2026 | 145 | 12.830 |
Why?
| | Military Personnel | 52 | 2025 | 726 | 8.610 |
Why?
| | Cyanides | 30 | 2026 | 58 | 8.360 |
Why?
| | Wounds and Injuries | 40 | 2026 | 959 | 6.470 |
Why?
| | Hydroxocobalamin | 17 | 2020 | 33 | 6.310 |
Why?
| | Emergency Medical Services | 33 | 2025 | 680 | 5.880 |
Why?
| | Air Ambulances | 15 | 2024 | 56 | 3.880 |
Why?
| | Swine | 41 | 2026 | 821 | 3.620 |
Why?
| | Resuscitation | 15 | 2024 | 314 | 3.590 |
Why?
| | Potassium Cyanide | 10 | 2026 | 24 | 3.520 |
Why?
| | Afghan Campaign 2001- | 31 | 2024 | 182 | 3.490 |
Why?
| | Cobamides | 8 | 2022 | 25 | 3.300 |
Why?
| | Military Medicine | 16 | 2026 | 148 | 3.190 |
Why?
| | Poisoning | 10 | 2025 | 119 | 3.150 |
Why?
| | Thiosulfates | 8 | 2021 | 19 | 2.910 |
Why?
| | Hydrogen Sulfide | 7 | 2022 | 47 | 2.690 |
Why?
| | Intubation, Intratracheal | 12 | 2025 | 330 | 2.690 |
Why?
| | Infusions, Intraosseous | 10 | 2024 | 20 | 2.480 |
Why?
| | Sulfides | 8 | 2025 | 92 | 2.370 |
Why?
| | Laryngoscopes | 5 | 2025 | 45 | 2.290 |
Why?
| | Hypotension | 11 | 2021 | 125 | 2.270 |
Why?
| | Warfare | 14 | 2026 | 99 | 2.210 |
Why?
| | Critical Care | 13 | 2026 | 706 | 2.150 |
Why?
| | Apnea | 5 | 2020 | 26 | 2.100 |
Why?
| | Hospitals, Military | 9 | 2018 | 29 | 2.070 |
Why?
| | Emergency Medicine | 10 | 2018 | 280 | 1.940 |
Why?
| | Airway Management | 5 | 2019 | 84 | 1.830 |
Why?
| | Hydrocodone | 5 | 2019 | 20 | 1.820 |
Why?
| | Heart Arrest | 8 | 2024 | 411 | 1.800 |
Why?
| | Disease Models, Animal | 30 | 2026 | 4580 | 1.750 |
Why?
| | Iraq War, 2003-2011 | 19 | 2024 | 163 | 1.730 |
Why?
| | Laryngoscopy | 6 | 2025 | 122 | 1.710 |
Why?
| | Emergency Service, Hospital | 18 | 2026 | 2363 | 1.710 |
Why?
| | Analgesics, Opioid | 15 | 2020 | 1221 | 1.670 |
Why?
| | Hemorrhage | 11 | 2025 | 825 | 1.610 |
Why?
| | Afghanistan | 16 | 2024 | 96 | 1.510 |
Why?
| | Analgesics | 5 | 2024 | 230 | 1.500 |
Why?
| | Antidepressive Agents, Tricyclic | 6 | 2014 | 30 | 1.450 |
Why?
| | Transportation of Patients | 3 | 2018 | 62 | 1.420 |
Why?
| | Humans | 181 | 2026 | 146342 | 1.410 |
Why?
| | Injury Severity Score | 18 | 2026 | 572 | 1.390 |
Why?
| | Mass Casualty Incidents | 7 | 2022 | 52 | 1.360 |
Why?
| | Critical Illness | 12 | 2025 | 908 | 1.360 |
Why?
| | Ketamine | 6 | 2024 | 144 | 1.350 |
Why?
| | Shock, Hemorrhagic | 6 | 2024 | 195 | 1.330 |
Why?
| | Poison Control Centers | 9 | 2017 | 85 | 1.310 |
Why?
| | Prospective Studies | 33 | 2026 | 8123 | 1.250 |
Why?
| | Male | 106 | 2026 | 73396 | 1.250 |
Why?
| | Female | 103 | 2026 | 79499 | 1.250 |
Why?
| | Brain Injuries, Traumatic | 6 | 2023 | 466 | 1.230 |
Why?
| | Sulfhydryl Compounds | 5 | 2022 | 189 | 1.220 |
Why?
| | Airway Obstruction | 3 | 2018 | 152 | 1.210 |
Why?
| | Animals | 67 | 2026 | 38107 | 1.190 |
Why?
| | Oxygen Inhalation Therapy | 7 | 2026 | 190 | 1.170 |
Why?
| | Heart Massage | 3 | 2019 | 11 | 1.160 |
Why?
| | Research | 6 | 2022 | 421 | 1.150 |
Why?
| | Cardiopulmonary Resuscitation | 5 | 2020 | 334 | 1.140 |
Why?
| | Toxicology | 4 | 2018 | 49 | 1.130 |
Why?
| | Adult | 75 | 2026 | 41087 | 1.120 |
Why?
| | Pressure | 2 | 2020 | 221 | 1.100 |
Why?
| | Retrospective Studies | 45 | 2026 | 17438 | 1.100 |
Why?
| | Drug Overdose | 10 | 2016 | 377 | 1.090 |
Why?
| | Brugada Syndrome | 4 | 2008 | 14 | 1.020 |
Why?
| | Registries | 20 | 2025 | 2400 | 1.020 |
Why?
| | Patient Transfer | 3 | 2019 | 224 | 0.990 |
Why?
| | Acute Pain | 3 | 2024 | 58 | 0.990 |
Why?
| | Blood Transfusion | 8 | 2025 | 394 | 0.980 |
Why?
| | Amitriptyline | 4 | 2011 | 25 | 0.970 |
Why?
| | Respiration, Artificial | 6 | 2023 | 711 | 0.950 |
Why?
| | Sodium Nitrite | 4 | 2016 | 39 | 0.940 |
Why?
| | Injections, Intramuscular | 8 | 2024 | 140 | 0.930 |
Why?
| | Opioid-Related Disorders | 7 | 2019 | 634 | 0.920 |
Why?
| | Random Allocation | 7 | 2020 | 366 | 0.910 |
Why?
| | Sodium Bicarbonate | 6 | 2016 | 48 | 0.910 |
Why?
| | Oxygen | 8 | 2026 | 997 | 0.910 |
Why?
| | United States | 43 | 2025 | 16136 | 0.900 |
Why?
| | Pain Measurement | 3 | 2018 | 573 | 0.900 |
Why?
| | Hydrogen Cyanide | 3 | 2022 | 5 | 0.900 |
Why?
| | Tandem Mass Spectrometry | 6 | 2023 | 576 | 0.880 |
Why?
| | Hydromorphone | 3 | 2016 | 10 | 0.870 |
Why?
| | Wounds, Penetrating | 3 | 2023 | 71 | 0.870 |
Why?
| | Craniocerebral Trauma | 2 | 2020 | 173 | 0.860 |
Why?
| | Pain Management | 5 | 2024 | 421 | 0.840 |
Why?
| | Hemodynamics | 11 | 2023 | 1114 | 0.840 |
Why?
| | Substance Abuse Detection | 4 | 2019 | 110 | 0.830 |
Why?
| | Heart Ventricles | 3 | 2020 | 762 | 0.830 |
Why?
| | War-Related Injuries | 3 | 2021 | 46 | 0.830 |
Why?
| | Sus scrofa | 8 | 2024 | 64 | 0.800 |
Why?
| | Balloon Occlusion | 2 | 2024 | 39 | 0.800 |
Why?
| | Snake Bites | 5 | 2019 | 24 | 0.800 |
Why?
| | Blood Pressure | 10 | 2018 | 1765 | 0.800 |
Why?
| | Freeze Drying | 1 | 2024 | 79 | 0.790 |
Why?
| | Remote Consultation | 2 | 2015 | 67 | 0.790 |
Why?
| | Wounds, Gunshot | 3 | 2022 | 262 | 0.770 |
Why?
| | Chromatography, Liquid | 4 | 2022 | 453 | 0.760 |
Why?
| | Tetrathionic Acid | 2 | 2021 | 4 | 0.760 |
Why?
| | Plasma | 2 | 2024 | 222 | 0.750 |
Why?
| | Time Factors | 15 | 2024 | 7109 | 0.740 |
Why?
| | Hypocalcemia | 4 | 2026 | 40 | 0.740 |
Why?
| | Burns | 5 | 2025 | 365 | 0.730 |
Why?
| | Environmental Exposure | 4 | 2019 | 578 | 0.730 |
Why?
| | Trauma Centers | 7 | 2026 | 441 | 0.730 |
Why?
| | Internship and Residency | 4 | 2016 | 1281 | 0.680 |
Why?
| | Acetylcysteine | 2 | 2014 | 139 | 0.680 |
Why?
| | Compartment Syndromes | 1 | 2022 | 36 | 0.680 |
Why?
| | Saline Solution, Hypertonic | 2 | 2014 | 43 | 0.670 |
Why?
| | Iraq | 9 | 2023 | 66 | 0.660 |
Why?
| | Aorta | 2 | 2024 | 440 | 0.660 |
Why?
| | Administration, Intravenous | 5 | 2019 | 172 | 0.660 |
Why?
| | Young Adult | 29 | 2025 | 14330 | 0.650 |
Why?
| | Pain | 5 | 2018 | 790 | 0.650 |
Why?
| | Acetaminophen | 3 | 2014 | 268 | 0.640 |
Why?
| | Epinephrine | 5 | 2022 | 160 | 0.640 |
Why?
| | Blast Injuries | 6 | 2021 | 62 | 0.620 |
Why?
| | Morphine | 3 | 2017 | 171 | 0.620 |
Why?
| | Thorax | 1 | 2020 | 51 | 0.620 |
Why?
| | Thiadiazoles | 1 | 2020 | 25 | 0.610 |
Why?
| | Patient Handoff | 1 | 2020 | 45 | 0.610 |
Why?
| | Cannabinoids | 2 | 2012 | 182 | 0.600 |
Why?
| | Antivenins | 4 | 2013 | 29 | 0.590 |
Why?
| | Chemically-Induced Disorders | 1 | 2019 | 2 | 0.590 |
Why?
| | Infusions, Intravenous | 8 | 2020 | 432 | 0.590 |
Why?
| | Administration, Oral | 6 | 2021 | 872 | 0.580 |
Why?
| | Firearms | 3 | 2022 | 444 | 0.570 |
Why?
| | Hydroxyethyl Starch Derivatives | 1 | 2018 | 9 | 0.570 |
Why?
| | Humerus | 3 | 2022 | 40 | 0.550 |
Why?
| | Amputation, Traumatic | 1 | 2018 | 21 | 0.540 |
Why?
| | Ventricular Fibrillation | 1 | 2018 | 63 | 0.540 |
Why?
| | Norepinephrine | 1 | 2019 | 201 | 0.540 |
Why?
| | Nursing Care | 1 | 2018 | 37 | 0.540 |
Why?
| | Cricoid Cartilage | 2 | 2015 | 16 | 0.540 |
Why?
| | Emergency Treatment | 4 | 2018 | 122 | 0.530 |
Why?
| | Glycine | 1 | 2019 | 184 | 0.530 |
Why?
| | Monitoring, Physiologic | 7 | 2021 | 279 | 0.530 |
Why?
| | Military Facilities | 1 | 2017 | 4 | 0.530 |
Why?
| | Preceptorship | 1 | 2018 | 68 | 0.530 |
Why?
| | Tablets | 1 | 2017 | 41 | 0.530 |
Why?
| | Cardiovascular Agents | 1 | 2019 | 165 | 0.510 |
Why?
| | Middle Aged | 36 | 2026 | 36619 | 0.510 |
Why?
| | Evidence-Based Emergency Medicine | 2 | 2016 | 4 | 0.500 |
Why?
| | Treatment Outcome | 18 | 2026 | 11821 | 0.500 |
Why?
| | Fellowships and Scholarships | 3 | 2016 | 355 | 0.500 |
Why?
| | Thiocyanates | 6 | 2024 | 28 | 0.500 |
Why?
| | Chronic Pain | 3 | 2020 | 304 | 0.500 |
Why?
| | Hyperoxia | 4 | 2023 | 126 | 0.480 |
Why?
| | Gas Poisoning | 1 | 2016 | 4 | 0.480 |
Why?
| | Oseltamivir | 1 | 2016 | 17 | 0.480 |
Why?
| | Emergency Medical Technicians | 1 | 2016 | 40 | 0.480 |
Why?
| | Abdominal Pain | 2 | 2019 | 149 | 0.480 |
Why?
| | Tourniquets | 3 | 2021 | 34 | 0.480 |
Why?
| | Smoke Inhalation Injury | 1 | 2016 | 29 | 0.470 |
Why?
| | Altitude | 1 | 2020 | 469 | 0.470 |
Why?
| | Tibia | 2 | 2014 | 177 | 0.450 |
Why?
| | Hypoxia | 5 | 2026 | 1211 | 0.450 |
Why?
| | Antifibrinolytic Agents | 3 | 2023 | 68 | 0.440 |
Why?
| | Lipopolysaccharides | 1 | 2019 | 861 | 0.440 |
Why?
| | Tranexamic Acid | 3 | 2023 | 63 | 0.440 |
Why?
| | Adolescent | 26 | 2025 | 22557 | 0.440 |
Why?
| | Incidence | 12 | 2026 | 2936 | 0.440 |
Why?
| | South Africa | 4 | 2024 | 262 | 0.440 |
Why?
| | Telemedicine | 2 | 2015 | 966 | 0.440 |
Why?
| | Acidosis, Lactic | 1 | 2015 | 46 | 0.440 |
Why?
| | Out-of-Hospital Cardiac Arrest | 1 | 2016 | 121 | 0.440 |
Why?
| | Substance-Related Disorders | 4 | 2017 | 1100 | 0.430 |
Why?
| | Wound Infection | 2 | 2026 | 60 | 0.430 |
Why?
| | Hematinics | 1 | 2015 | 22 | 0.430 |
Why?
| | Vascular System Injuries | 2 | 2026 | 79 | 0.430 |
Why?
| | Diphenhydramine | 2 | 2015 | 36 | 0.420 |
Why?
| | Asphyxia | 1 | 2014 | 24 | 0.420 |
Why?
| | Electrocardiography | 5 | 2012 | 667 | 0.420 |
Why?
| | Patient Simulation | 1 | 2014 | 42 | 0.420 |
Why?
| | Efficiency | 1 | 2015 | 102 | 0.410 |
Why?
| | Solvents | 2 | 2004 | 112 | 0.410 |
Why?
| | Tracheotomy | 1 | 2014 | 23 | 0.400 |
Why?
| | Awards and Prizes | 1 | 2015 | 72 | 0.400 |
Why?
| | Self Report | 2 | 2017 | 870 | 0.400 |
Why?
| | Exsanguination | 1 | 2013 | 18 | 0.400 |
Why?
| | Anemia | 1 | 2015 | 190 | 0.400 |
Why?
| | Dietary Supplements | 1 | 2017 | 587 | 0.380 |
Why?
| | Tracheostomy | 1 | 2015 | 136 | 0.380 |
Why?
| | Texas | 5 | 2017 | 280 | 0.380 |
Why?
| | Superior Mesenteric Artery Syndrome | 1 | 2013 | 8 | 0.380 |
Why?
| | Burns, Chemical | 2 | 2017 | 32 | 0.380 |
Why?
| | Mobile Health Units | 2 | 2012 | 21 | 0.380 |
Why?
| | Glyoxylates | 2 | 2023 | 8 | 0.370 |
Why?
| | Practice Patterns, Physicians' | 3 | 2020 | 1408 | 0.370 |
Why?
| | Forensic Medicine | 1 | 2012 | 19 | 0.370 |
Why?
| | Chemical and Drug Induced Liver Injury | 1 | 2014 | 138 | 0.370 |
Why?
| | Aerospace Medicine | 3 | 2017 | 32 | 0.370 |
Why?
| | Viperidae | 2 | 2011 | 6 | 0.360 |
Why?
| | Chi-Square Distribution | 4 | 2019 | 517 | 0.360 |
Why?
| | Methanol | 2 | 2016 | 43 | 0.360 |
Why?
| | Hyperalgesia | 1 | 2012 | 127 | 0.340 |
Why?
| | Metformin | 1 | 2015 | 328 | 0.340 |
Why?
| | Seizures | 3 | 2013 | 489 | 0.340 |
Why?
| | Fires | 1 | 2012 | 76 | 0.340 |
Why?
| | Wounds, Nonpenetrating | 3 | 2026 | 305 | 0.340 |
Why?
| | Vitamin B 12 | 1 | 2012 | 140 | 0.340 |
Why?
| | Gas Chromatography-Mass Spectrometry | 3 | 2020 | 124 | 0.340 |
Why?
| | Education, Medical | 1 | 2014 | 274 | 0.340 |
Why?
| | Bone and Bones | 1 | 2014 | 319 | 0.330 |
Why?
| | Renal Dialysis | 1 | 2015 | 461 | 0.330 |
Why?
| | Injections, Intravenous | 5 | 2018 | 197 | 0.330 |
Why?
| | Mass Screening | 2 | 2018 | 1307 | 0.330 |
Why?
| | Gait | 1 | 2014 | 322 | 0.330 |
Why?
| | Fluid Therapy | 3 | 2019 | 154 | 0.330 |
Why?
| | Extremities | 2 | 2022 | 142 | 0.320 |
Why?
| | Waiting Lists | 1 | 2012 | 251 | 0.320 |
Why?
| | Blood Component Transfusion | 2 | 2024 | 99 | 0.310 |
Why?
| | Survival Rate | 6 | 2018 | 2092 | 0.310 |
Why?
| | Endovascular Procedures | 2 | 2026 | 390 | 0.310 |
Why?
| | Antiviral Agents | 1 | 2016 | 779 | 0.310 |
Why?
| | Influenza, Human | 1 | 2016 | 640 | 0.310 |
Why?
| | Referral and Consultation | 1 | 2016 | 881 | 0.310 |
Why?
| | Medical Records | 2 | 2021 | 193 | 0.310 |
Why?
| | Lung | 2 | 2020 | 4122 | 0.310 |
Why?
| | Calcium | 3 | 2026 | 1181 | 0.300 |
Why?
| | Surveys and Questionnaires | 9 | 2025 | 6073 | 0.290 |
Why?
| | Survival Analysis | 4 | 2021 | 1378 | 0.280 |
Why?
| | Immunoglobulin Fragments | 1 | 2008 | 11 | 0.280 |
Why?
| | Prescription Drug Misuse | 4 | 2020 | 58 | 0.280 |
Why?
| | Research Design | 5 | 2026 | 1143 | 0.280 |
Why?
| | Guideline Adherence | 4 | 2023 | 594 | 0.280 |
Why?
| | Omeprazole | 1 | 2008 | 9 | 0.270 |
Why?
| | Vascular Resistance | 3 | 2015 | 365 | 0.270 |
Why?
| | Rhabdomyolysis | 1 | 2008 | 24 | 0.270 |
Why?
| | Immunoglobulin Fab Fragments | 2 | 2008 | 55 | 0.270 |
Why?
| | Hydrothorax | 1 | 2007 | 3 | 0.270 |
Why?
| | Hyponatremia | 1 | 2008 | 42 | 0.260 |
Why?
| | Drug Therapy, Combination | 4 | 2019 | 1036 | 0.260 |
Why?
| | Coma | 2 | 2022 | 39 | 0.260 |
Why?
| | Scalp | 1 | 2007 | 38 | 0.260 |
Why?
| | Health Knowledge, Attitudes, Practice | 1 | 2016 | 1408 | 0.260 |
Why?
| | Proton Pump Inhibitors | 1 | 2008 | 101 | 0.260 |
Why?
| | Phosphorus | 1 | 2007 | 89 | 0.250 |
Why?
| | Clinical Competence | 4 | 2026 | 1272 | 0.250 |
Why?
| | Physicians | 5 | 2019 | 955 | 0.250 |
Why?
| | Limit of Detection | 4 | 2023 | 92 | 0.250 |
Why?
| | Psoas Abscess | 1 | 2006 | 2 | 0.250 |
Why?
| | Video Recording | 2 | 2025 | 219 | 0.250 |
Why?
| | Practice Guidelines as Topic | 2 | 2017 | 1591 | 0.250 |
Why?
| | Methicillin Resistance | 1 | 2006 | 17 | 0.250 |
Why?
| | Linear Models | 3 | 2015 | 857 | 0.250 |
Why?
| | Formates | 1 | 2006 | 15 | 0.240 |
Why?
| | Delirium | 1 | 2008 | 107 | 0.240 |
Why?
| | Explosions | 2 | 2021 | 14 | 0.240 |
Why?
| | Poisons | 2 | 2019 | 20 | 0.240 |
Why?
| | Metabolomics | 2 | 2025 | 738 | 0.240 |
Why?
| | Models, Animal | 3 | 2024 | 387 | 0.240 |
Why?
| | Blindness | 1 | 2006 | 51 | 0.240 |
Why?
| | Cerebrovascular Trauma | 1 | 2026 | 22 | 0.240 |
Why?
| | Infant | 10 | 2021 | 10114 | 0.240 |
Why?
| | Toxicity Tests, Acute | 2 | 2018 | 8 | 0.240 |
Why?
| | Rabbits | 5 | 2021 | 651 | 0.230 |
Why?
| | Hypothermia | 2 | 2024 | 53 | 0.230 |
Why?
| | Platinum | 1 | 2026 | 48 | 0.230 |
Why?
| | Cohort Studies | 6 | 2023 | 6077 | 0.230 |
Why?
| | Hypercalcemia | 1 | 2026 | 23 | 0.230 |
Why?
| | Kaplan-Meier Estimate | 2 | 2018 | 970 | 0.230 |
Why?
| | Pilot Projects | 5 | 2026 | 1888 | 0.230 |
Why?
| | Hypoglycemic Agents | 1 | 2015 | 1412 | 0.220 |
Why?
| | Zebrafish | 2 | 2022 | 536 | 0.220 |
Why?
| | Fentanyl | 2 | 2017 | 126 | 0.220 |
Why?
| | Methionine | 1 | 2026 | 160 | 0.220 |
Why?
| | Tertiary Care Centers | 2 | 2017 | 196 | 0.220 |
Why?
| | Intention | 1 | 2007 | 187 | 0.220 |
Why?
| | Child, Preschool | 10 | 2021 | 11913 | 0.220 |
Why?
| | Cocaine | 1 | 2007 | 162 | 0.220 |
Why?
| | Administration, Intranasal | 1 | 2025 | 95 | 0.220 |
Why?
| | Hospitals | 2 | 2022 | 738 | 0.220 |
Why?
| | Biomarkers | 4 | 2024 | 4340 | 0.220 |
Why?
| | Psychotropic Drugs | 1 | 2005 | 75 | 0.220 |
Why?
| | Travel | 2 | 2016 | 134 | 0.220 |
Why?
| | Patient Care Team | 2 | 2026 | 701 | 0.220 |
Why?
| | Crotalid Venoms | 2 | 2011 | 30 | 0.220 |
Why?
| | Coated Materials, Biocompatible | 1 | 2025 | 64 | 0.220 |
Why?
| | Fat Emulsions, Intravenous | 2 | 2015 | 29 | 0.220 |
Why?
| | Pneumonia, Ventilator-Associated | 1 | 2025 | 58 | 0.210 |
Why?
| | Diagnosis, Differential | 4 | 2015 | 1503 | 0.210 |
Why?
| | Double-Blind Method | 2 | 2015 | 2070 | 0.210 |
Why?
| | Hydrocarbons | 1 | 2004 | 29 | 0.210 |
Why?
| | Risk | 2 | 2018 | 920 | 0.210 |
Why?
| | Cannabis | 1 | 2012 | 521 | 0.210 |
Why?
| | Terpenes | 1 | 2004 | 25 | 0.210 |
Why?
| | Echocardiography | 2 | 2018 | 645 | 0.210 |
Why?
| | Feedback | 1 | 2025 | 183 | 0.210 |
Why?
| | Equipment Reuse | 1 | 2024 | 18 | 0.200 |
Why?
| | Suicide, Attempted | 4 | 2015 | 391 | 0.200 |
Why?
| | Antibiotic Prophylaxis | 1 | 2025 | 140 | 0.200 |
Why?
| | Oxidative Phosphorylation | 1 | 2025 | 212 | 0.200 |
Why?
| | Child | 15 | 2021 | 22693 | 0.200 |
Why?
| | Forecasting | 1 | 2005 | 388 | 0.200 |
Why?
| | Crotalus | 1 | 2004 | 24 | 0.200 |
Why?
| | Neck Injuries | 1 | 2023 | 22 | 0.200 |
Why?
| | Animal Experimentation | 1 | 2003 | 8 | 0.190 |
Why?
| | Glycolysis | 1 | 2025 | 342 | 0.190 |
Why?
| | Cross-Sectional Studies | 3 | 2024 | 5899 | 0.190 |
Why?
| | Shock, Traumatic | 1 | 2023 | 14 | 0.190 |
Why?
| | Mycophenolic Acid | 1 | 2004 | 117 | 0.190 |
Why?
| | Noninvasive Ventilation | 1 | 2024 | 66 | 0.190 |
Why?
| | Glasgow Coma Scale | 1 | 2004 | 211 | 0.190 |
Why?
| | Anti-Infective Agents | 1 | 2025 | 234 | 0.180 |
Why?
| | Plant Extracts | 1 | 2004 | 192 | 0.180 |
Why?
| | Ventilators, Mechanical | 1 | 2023 | 70 | 0.180 |
Why?
| | Tomography, X-Ray Computed | 1 | 2013 | 2786 | 0.180 |
Why?
| | Staphylococcus aureus | 1 | 2006 | 459 | 0.180 |
Why?
| | Staphylococcal Infections | 1 | 2006 | 397 | 0.180 |
Why?
| | Fibrinolysis | 1 | 2023 | 162 | 0.180 |
Why?
| | Seasons | 1 | 2024 | 540 | 0.170 |
Why?
| | Toxicokinetics | 2 | 2018 | 8 | 0.170 |
Why?
| | Follow-Up Studies | 5 | 2017 | 5439 | 0.170 |
Why?
| | Aged | 10 | 2026 | 26432 | 0.160 |
Why?
| | Soil Pollutants | 1 | 2020 | 16 | 0.160 |
Why?
| | Heart Rate | 3 | 2015 | 846 | 0.160 |
Why?
| | Emergency Responders | 1 | 2021 | 38 | 0.160 |
Why?
| | Lactates | 2 | 2012 | 82 | 0.160 |
Why?
| | Clinical Trials as Topic | 1 | 2026 | 1064 | 0.160 |
Why?
| | Personal Protective Equipment | 1 | 2021 | 59 | 0.160 |
Why?
| | Memory | 1 | 2023 | 298 | 0.160 |
Why?
| | Guidelines as Topic | 3 | 2017 | 267 | 0.160 |
Why?
| | Disulfides | 1 | 2020 | 93 | 0.160 |
Why?
| | Calcium-Calmodulin-Dependent Protein Kinase Type 2 | 1 | 2023 | 199 | 0.160 |
Why?
| | Feasibility Studies | 2 | 2023 | 1135 | 0.160 |
Why?
| | Prescription Drug Monitoring Programs | 1 | 2020 | 18 | 0.160 |
Why?
| | Inhalation Exposure | 1 | 2020 | 103 | 0.150 |
Why?
| | Patient Outcome Assessment | 2 | 2021 | 129 | 0.150 |
Why?
| | Agkistrodon | 1 | 2019 | 6 | 0.150 |
Why?
| | Thiazoles | 2 | 2024 | 139 | 0.150 |
Why?
| | Consensus | 2 | 2021 | 467 | 0.150 |
Why?
| | Brain Injuries | 2 | 2023 | 499 | 0.150 |
Why?
| | Haloperidol | 1 | 2019 | 27 | 0.140 |
Why?
| | Immunosuppressive Agents | 1 | 2004 | 829 | 0.140 |
Why?
| | Ketorolac | 1 | 2019 | 33 | 0.140 |
Why?
| | Brain Concussion | 2 | 2023 | 660 | 0.140 |
Why?
| | Gases | 1 | 2019 | 45 | 0.140 |
Why?
| | Adrenergic Agonists | 1 | 2018 | 5 | 0.140 |
Why?
| | Randomized Controlled Trials as Topic | 5 | 2026 | 1763 | 0.140 |
Why?
| | Terrorism | 1 | 2018 | 25 | 0.140 |
Why?
| | Sodium Cyanide | 1 | 2018 | 1 | 0.140 |
Why?
| | Blood Circulation | 1 | 2018 | 43 | 0.140 |
Why?
| | Tympanic Membrane Perforation | 2 | 2009 | 15 | 0.140 |
Why?
| | Pyruvate Dehydrogenase Complex | 1 | 2018 | 9 | 0.140 |
Why?
| | Logistic Models | 3 | 2024 | 2126 | 0.140 |
Why?
| | Documentation | 1 | 2020 | 202 | 0.140 |
Why?
| | Harm Reduction | 1 | 2019 | 49 | 0.140 |
Why?
| | Torso | 1 | 2018 | 36 | 0.130 |
Why?
| | Reproducibility of Results | 3 | 2013 | 3416 | 0.130 |
Why?
| | Dextropropoxyphene | 1 | 2017 | 4 | 0.130 |
Why?
| | Cholinesterase Inhibitors | 1 | 2018 | 47 | 0.130 |
Why?
| | War Exposure | 1 | 2018 | 14 | 0.130 |
Why?
| | Analysis of Variance | 2 | 2017 | 1298 | 0.130 |
Why?
| | Methemoglobinemia | 1 | 2017 | 13 | 0.130 |
Why?
| | Burns, Inhalation | 1 | 2017 | 9 | 0.130 |
Why?
| | Tramadol | 1 | 2017 | 17 | 0.130 |
Why?
| | Blood Proteins | 1 | 2019 | 239 | 0.130 |
Why?
| | Saliva | 1 | 2019 | 256 | 0.130 |
Why?
| | Vascular Access Devices | 1 | 2018 | 30 | 0.130 |
Why?
| | Solid Phase Extraction | 2 | 2019 | 28 | 0.130 |
Why?
| | Drug Prescriptions | 2 | 2020 | 314 | 0.130 |
Why?
| | Tidal Volume | 1 | 2018 | 108 | 0.130 |
Why?
| | Stroke | 1 | 2026 | 1287 | 0.130 |
Why?
| | Acidosis | 2 | 2009 | 105 | 0.130 |
Why?
| | Rescue Work | 1 | 2017 | 11 | 0.130 |
Why?
| | Statistics, Nonparametric | 1 | 2018 | 426 | 0.120 |
Why?
| | Disease Management | 3 | 2017 | 651 | 0.120 |
Why?
| | Dextromethorphan | 1 | 2016 | 24 | 0.120 |
Why?
| | Blood Coagulation | 1 | 2018 | 267 | 0.120 |
Why?
| | Antacids | 1 | 2016 | 16 | 0.120 |
Why?
| | Hemoglobins | 2 | 2018 | 384 | 0.120 |
Why?
| | Cognition | 1 | 2025 | 1292 | 0.120 |
Why?
| | Headache | 1 | 2017 | 150 | 0.120 |
Why?
| | Attention Deficit Disorder with Hyperactivity | 2 | 2015 | 422 | 0.120 |
Why?
| | Telephone | 1 | 2017 | 175 | 0.120 |
Why?
| | Sodium Chloride | 1 | 2017 | 138 | 0.120 |
Why?
| | Epidemics | 1 | 2018 | 97 | 0.120 |
Why?
| | Educational Status | 2 | 2016 | 466 | 0.120 |
Why?
| | Shock, Septic | 1 | 2019 | 230 | 0.120 |
Why?
| | Combined Modality Therapy | 2 | 2017 | 1271 | 0.120 |
Why?
| | Musculoskeletal Diseases | 1 | 2017 | 95 | 0.120 |
Why?
| | Medical Errors | 1 | 2017 | 124 | 0.120 |
Why?
| | Decision Trees | 1 | 2016 | 76 | 0.120 |
Why?
| | Inpatients | 1 | 2020 | 540 | 0.120 |
Why?
| | Clinical Protocols | 1 | 2018 | 282 | 0.120 |
Why?
| | Pharmacy Service, Hospital | 1 | 2017 | 90 | 0.120 |
Why?
| | Point-of-Care Testing | 1 | 2016 | 36 | 0.120 |
Why?
| | Anti-Inflammatory Agents, Non-Steroidal | 1 | 2019 | 344 | 0.120 |
Why?
| | Antimetabolites, Antineoplastic | 1 | 2016 | 108 | 0.120 |
Why?
| | Heart Diseases | 1 | 2019 | 343 | 0.120 |
Why?
| | Prescription Drug Diversion | 1 | 2015 | 14 | 0.110 |
Why?
| | Algorithms | 2 | 2016 | 1849 | 0.110 |
Why?
| | Massachusetts | 1 | 2016 | 178 | 0.110 |
Why?
| | Gastrointestinal Diseases | 1 | 2017 | 220 | 0.110 |
Why?
| | Radiation Injuries | 1 | 2017 | 149 | 0.110 |
Why?
| | Benzodiazepines | 1 | 2016 | 158 | 0.110 |
Why?
| | Prognosis | 2 | 2019 | 4351 | 0.110 |
Why?
| | Drug Utilization Review | 1 | 2015 | 60 | 0.110 |
Why?
| | Methotrexate | 1 | 2016 | 234 | 0.110 |
Why?
| | Angiography | 2 | 2013 | 206 | 0.110 |
Why?
| | Sepsis | 1 | 2021 | 669 | 0.110 |
Why?
| | Equipment Design | 2 | 2024 | 520 | 0.110 |
Why?
| | Drug Costs | 1 | 2016 | 116 | 0.110 |
Why?
| | Phenols | 1 | 2015 | 106 | 0.110 |
Why?
| | Disaster Planning | 1 | 2016 | 111 | 0.110 |
Why?
| | Zebrafish Proteins | 1 | 2018 | 314 | 0.110 |
Why?
| | Proteome | 1 | 2019 | 520 | 0.110 |
Why?
| | Proportional Hazards Models | 1 | 2018 | 1331 | 0.110 |
Why?
| | Metabolome | 1 | 2018 | 390 | 0.110 |
Why?
| | Breast Neoplasms | 1 | 2007 | 2418 | 0.110 |
Why?
| | Practice Patterns, Nurses' | 1 | 2014 | 20 | 0.100 |
Why?
| | Vitamin B Complex | 1 | 2014 | 39 | 0.100 |
Why?
| | Anti-Bacterial Agents | 1 | 2025 | 1942 | 0.100 |
Why?
| | Nurses | 1 | 2016 | 171 | 0.100 |
Why?
| | Shock | 2 | 2012 | 101 | 0.100 |
Why?
| | Thyroid Cartilage | 1 | 2014 | 3 | 0.100 |
Why?
| | Health Services Research | 1 | 2016 | 390 | 0.100 |
Why?
| | Aspartate Aminotransferases | 1 | 2014 | 86 | 0.100 |
Why?
| | Liver Function Tests | 1 | 2014 | 103 | 0.100 |
Why?
| | Teaching Rounds | 1 | 2015 | 74 | 0.100 |
Why?
| | Alanine Transaminase | 1 | 2014 | 151 | 0.100 |
Why?
| | Societies, Medical | 1 | 2018 | 907 | 0.100 |
Why?
| | Drug-Related Side Effects and Adverse Reactions | 1 | 2016 | 266 | 0.100 |
Why?
| | Ketoglutaric Acids | 1 | 2013 | 23 | 0.100 |
Why?
| | Mortality | 1 | 2016 | 375 | 0.100 |
Why?
| | Mentors | 1 | 2015 | 217 | 0.100 |
Why?
| | Ischemia | 2 | 2014 | 421 | 0.100 |
Why?
| | Necrosis | 1 | 2014 | 243 | 0.100 |
Why?
| | Anesthesia, General | 1 | 2014 | 124 | 0.100 |
Why?
| | Length of Stay | 2 | 2016 | 1358 | 0.090 |
Why?
| | Anesthetics | 1 | 2014 | 100 | 0.090 |
Why?
| | Central Nervous System Stimulants | 1 | 2015 | 183 | 0.090 |
Why?
| | Health Surveys | 1 | 2015 | 511 | 0.090 |
Why?
| | Oximetry | 2 | 2026 | 124 | 0.090 |
Why?
| | Academic Medical Centers | 1 | 2016 | 561 | 0.090 |
Why?
| | Aged, 80 and over | 3 | 2016 | 8391 | 0.090 |
Why?
| | Drug Combinations | 1 | 2014 | 400 | 0.090 |
Why?
| | Data Collection | 1 | 2015 | 650 | 0.090 |
Why?
| | Dose-Response Relationship, Drug | 2 | 2018 | 2022 | 0.090 |
Why?
| | Common Cold | 1 | 2012 | 16 | 0.090 |
Why?
| | Drug Stability | 1 | 2013 | 172 | 0.090 |
Why?
| | Proteomics | 1 | 2019 | 1203 | 0.090 |
Why?
| | Respiratory System Agents | 1 | 2012 | 22 | 0.090 |
Why?
| | Multicenter Studies as Topic | 2 | 2026 | 417 | 0.090 |
Why?
| | Chromatography, Thin Layer | 1 | 2012 | 24 | 0.090 |
Why?
| | Cadaver | 2 | 2024 | 304 | 0.090 |
Why?
| | Basilar Artery | 1 | 2012 | 7 | 0.090 |
Why?
| | Nitriles | 1 | 2013 | 212 | 0.090 |
Why?
| | Cues | 1 | 2014 | 326 | 0.090 |
Why?
| | Blood Chemical Analysis | 1 | 2012 | 109 | 0.090 |
Why?
| | Chromatography, High Pressure Liquid | 3 | 2023 | 588 | 0.090 |
Why?
| | Nonprescription Drugs | 1 | 2012 | 68 | 0.090 |
Why?
| | Safety | 2 | 2013 | 347 | 0.090 |
Why?
| | Burn Units | 2 | 2025 | 40 | 0.090 |
Why?
| | Cough | 1 | 2012 | 123 | 0.080 |
Why?
| | Fever | 1 | 2013 | 322 | 0.080 |
Why?
| | Triage | 2 | 2017 | 243 | 0.080 |
Why?
| | Arterial Occlusive Diseases | 1 | 2012 | 88 | 0.080 |
Why?
| | Risk Assessment | 2 | 2018 | 3712 | 0.080 |
Why?
| | Abbreviated Injury Scale | 2 | 2021 | 28 | 0.080 |
Why?
| | Femur | 1 | 2013 | 264 | 0.080 |
Why?
| | Health Care Surveys | 1 | 2012 | 541 | 0.080 |
Why?
| | Hydrogen-Ion Concentration | 1 | 2012 | 534 | 0.080 |
Why?
| | Drug Administration Routes | 1 | 2010 | 41 | 0.080 |
Why?
| | Needlestick Injuries | 1 | 2010 | 3 | 0.080 |
Why?
| | Patient Satisfaction | 1 | 2015 | 706 | 0.080 |
Why?
| | Sleep Stages | 1 | 2010 | 76 | 0.080 |
Why?
| | Nausea | 1 | 2010 | 111 | 0.080 |
Why?
| | Tissue Plasminogen Activator | 1 | 2012 | 245 | 0.080 |
Why?
| | Mice | 4 | 2023 | 18297 | 0.070 |
Why?
| | Vomiting | 1 | 2010 | 131 | 0.070 |
Why?
| | Manikins | 1 | 2009 | 37 | 0.070 |
Why?
| | Fibrinolytic Agents | 1 | 2012 | 303 | 0.070 |
Why?
| | Anaphylaxis | 1 | 2010 | 105 | 0.070 |
Why?
| | Allied Health Personnel | 1 | 2009 | 54 | 0.070 |
Why?
| | Intensive Care Units | 2 | 2025 | 925 | 0.070 |
Why?
| | Stress Disorders, Post-Traumatic | 1 | 2017 | 892 | 0.070 |
Why?
| | Curriculum | 1 | 2015 | 1079 | 0.070 |
Why?
| | Mental Health | 1 | 2015 | 779 | 0.070 |
Why?
| | Inservice Training | 1 | 2009 | 115 | 0.070 |
Why?
| | Sensitivity and Specificity | 1 | 2013 | 1998 | 0.070 |
Why?
| | Thoracostomy | 1 | 2007 | 26 | 0.070 |
Why?
| | Dermis | 1 | 2007 | 31 | 0.070 |
Why?
| | Unconsciousness | 1 | 2007 | 24 | 0.060 |
Why?
| | Arrhythmias, Cardiac | 1 | 2010 | 358 | 0.060 |
Why?
| | Spectrum Analysis | 2 | 2018 | 85 | 0.060 |
Why?
| | Electronic Health Records | 1 | 2015 | 1210 | 0.060 |
Why?
| | Fatal Outcome | 1 | 2007 | 302 | 0.060 |
Why?
| | Primary Health Care | 2 | 2020 | 1776 | 0.060 |
Why?
| | Sodium Channels | 1 | 2007 | 63 | 0.060 |
Why?
| | Risk Factors | 5 | 2017 | 10921 | 0.060 |
Why?
| | Decision Support Systems, Clinical | 2 | 2021 | 279 | 0.060 |
Why?
| | Severity of Illness Index | 1 | 2014 | 2921 | 0.060 |
Why?
| | Ukraine | 1 | 2026 | 37 | 0.060 |
Why?
| | Vasopressins | 1 | 2006 | 60 | 0.060 |
Why?
| | Decision Support Techniques | 1 | 2011 | 478 | 0.060 |
Why?
| | Atomoxetine Hydrochloride | 1 | 2005 | 8 | 0.060 |
Why?
| | Propylamines | 1 | 2005 | 11 | 0.060 |
Why?
| | Oxygen Consumption | 2 | 2019 | 721 | 0.060 |
Why?
| | Death, Sudden | 1 | 2005 | 26 | 0.060 |
Why?
| | Vasoconstrictor Agents | 1 | 2006 | 148 | 0.060 |
Why?
| | Valproic Acid | 1 | 2005 | 45 | 0.060 |
Why?
| | Treatment Failure | 1 | 2007 | 361 | 0.060 |
Why?
| | Analgesics, Non-Narcotic | 1 | 2007 | 129 | 0.060 |
Why?
| | Vasospasm, Intracranial | 1 | 2005 | 19 | 0.060 |
Why?
| | Administration, Inhalation | 1 | 2006 | 567 | 0.050 |
Why?
| | United States Department of Defense | 1 | 2025 | 26 | 0.050 |
Why?
| | Subarachnoid Hemorrhage | 1 | 2005 | 74 | 0.050 |
Why?
| | History, 21st Century | 1 | 2005 | 224 | 0.050 |
Why?
| | Dimethylformamide | 1 | 2004 | 1 | 0.050 |
Why?
| | Kerosene | 1 | 2004 | 1 | 0.050 |
Why?
| | Hexanones | 1 | 2004 | 2 | 0.050 |
Why?
| | Hexanes | 1 | 2004 | 3 | 0.050 |
Why?
| | Cyclohexenes | 1 | 2004 | 4 | 0.050 |
Why?
| | Task Performance and Analysis | 1 | 2026 | 203 | 0.050 |
Why?
| | Alkanes | 1 | 2004 | 9 | 0.050 |
Why?
| | Forensic Toxicology | 1 | 2024 | 3 | 0.050 |
Why?
| | Dimethyl Sulfoxide | 1 | 2004 | 42 | 0.050 |
Why?
| | Community-Acquired Infections | 1 | 2006 | 179 | 0.050 |
Why?
| | Linoleic Acid | 1 | 2004 | 44 | 0.050 |
Why?
| | Oleic Acid | 1 | 2004 | 40 | 0.050 |
Why?
| | History, 20th Century | 1 | 2005 | 330 | 0.050 |
Why?
| | Electric Power Supplies | 1 | 2024 | 46 | 0.050 |
Why?
| | Catheters | 1 | 2024 | 73 | 0.050 |
Why?
| | Data Interpretation, Statistical | 1 | 2026 | 368 | 0.050 |
Why?
| | Charcoal | 1 | 2004 | 28 | 0.050 |
Why?
| | Sorbitol | 1 | 2023 | 13 | 0.050 |
Why?
| | Blood Cell Count | 1 | 2004 | 56 | 0.050 |
Why?
| | Comprehension | 1 | 2005 | 175 | 0.050 |
Why?
| | Health Expenditures | 1 | 2005 | 198 | 0.050 |
Why?
| | Health Services Accessibility | 1 | 2012 | 1107 | 0.050 |
Why?
| | Simulation Training | 1 | 2026 | 136 | 0.050 |
Why?
| | Half-Life | 2 | 2014 | 157 | 0.050 |
Why?
| | Masks | 1 | 2024 | 70 | 0.050 |
Why?
| | Parents | 1 | 2012 | 1394 | 0.050 |
Why?
| | Acute Disease | 1 | 2026 | 1038 | 0.050 |
Why?
| | Lupus Nephritis | 1 | 2004 | 67 | 0.050 |
Why?
| | Rats | 2 | 2022 | 5586 | 0.050 |
Why?
| | Fibrin | 1 | 2004 | 84 | 0.050 |
Why?
| | Observer Variation | 1 | 2004 | 356 | 0.050 |
Why?
| | Anticonvulsants | 1 | 2005 | 253 | 0.050 |
Why?
| | Ambulances | 1 | 2023 | 52 | 0.050 |
Why?
| | Calcium, Dietary | 1 | 2023 | 52 | 0.050 |
Why?
| | Cross-Over Studies | 1 | 2025 | 615 | 0.050 |
Why?
| | Depressive Disorder | 1 | 2005 | 361 | 0.050 |
Why?
| | Biofilms | 1 | 2025 | 288 | 0.050 |
Why?
| | Fibrinogen | 1 | 2004 | 182 | 0.050 |
Why?
| | Specimen Handling | 1 | 2024 | 178 | 0.050 |
Why?
| | Hemostasis | 1 | 2023 | 100 | 0.050 |
Why?
| | Pyruvic Acid | 1 | 2022 | 51 | 0.040 |
Why?
| | Meta-Analysis as Topic | 1 | 2023 | 173 | 0.040 |
Why?
| | Intracranial Hemorrhages | 1 | 2023 | 106 | 0.040 |
Why?
| | Armed Conflicts | 1 | 2021 | 16 | 0.040 |
Why?
| | Bandages | 1 | 2021 | 38 | 0.040 |
Why?
| | Blood Coagulation Disorders | 1 | 2023 | 190 | 0.040 |
Why?
| | Cricetulus | 1 | 2021 | 115 | 0.040 |
Why?
| | Hypertension | 1 | 2010 | 1272 | 0.040 |
Why?
| | Aviation | 1 | 2021 | 10 | 0.040 |
Why?
| | CHO Cells | 1 | 2021 | 167 | 0.040 |
Why?
| | Fumigation | 1 | 2020 | 3 | 0.040 |
Why?
| | Temperature | 1 | 2024 | 635 | 0.040 |
Why?
| | Cricetinae | 1 | 2021 | 296 | 0.040 |
Why?
| | Sheep | 1 | 2004 | 870 | 0.040 |
Why?
| | Hydrazines | 1 | 2021 | 37 | 0.040 |
Why?
| | Rats, Sprague-Dawley | 2 | 2018 | 2537 | 0.040 |
Why?
| | Age Factors | 2 | 2019 | 3347 | 0.040 |
Why?
| | Databases, Factual | 1 | 2026 | 1493 | 0.040 |
Why?
| | Pesticides | 1 | 2020 | 59 | 0.040 |
Why?
| | Hospital Mortality | 1 | 2025 | 1051 | 0.040 |
Why?
| | Mammals | 1 | 2022 | 288 | 0.040 |
Why?
| | Hemolysis | 1 | 2022 | 242 | 0.040 |
Why?
| | Intersectoral Collaboration | 1 | 2020 | 64 | 0.040 |
Why?
| | Myocardial Infarction | 1 | 2007 | 1215 | 0.040 |
Why?
| | Regression Analysis | 1 | 2021 | 999 | 0.040 |
Why?
| | Spectrometry, Mass, Electrospray Ionization | 1 | 2019 | 175 | 0.040 |
Why?
| | Directive Counseling | 1 | 2019 | 48 | 0.040 |
Why?
| | Phosphorylation | 1 | 2023 | 1724 | 0.030 |
Why?
| | Quality Improvement | 2 | 2021 | 1354 | 0.030 |
Why?
| | Cholinesterase Reactivators | 1 | 2018 | 1 | 0.030 |
Why?
| | Organophosphate Poisoning | 1 | 2018 | 1 | 0.030 |
Why?
| | Electron Transport Complex IV | 1 | 2018 | 61 | 0.030 |
Why?
| | North America | 1 | 2019 | 300 | 0.030 |
Why?
| | Drug Storage | 1 | 2018 | 52 | 0.030 |
Why?
| | Multivariate Analysis | 1 | 2021 | 1543 | 0.030 |
Why?
| | Resource Allocation | 1 | 2018 | 45 | 0.030 |
Why?
| | Catheterization, Peripheral | 1 | 2019 | 116 | 0.030 |
Why?
| | Infant, Newborn | 2 | 2021 | 6460 | 0.030 |
Why?
| | Antipsychotic Agents | 1 | 2019 | 185 | 0.030 |
Why?
| | Hippocampus | 1 | 2023 | 989 | 0.030 |
Why?
| | Peptides | 1 | 2023 | 992 | 0.030 |
Why?
| | Hospitalization | 2 | 2019 | 2475 | 0.030 |
Why?
| | Chemical Warfare Agents | 1 | 2018 | 89 | 0.030 |
Why?
| | Multiple Trauma | 1 | 2018 | 118 | 0.030 |
Why?
| | Carbon Dioxide | 1 | 2018 | 228 | 0.030 |
Why?
| | United States Department of Veterans Affairs | 1 | 2020 | 777 | 0.030 |
Why?
| | Advisory Committees | 1 | 2016 | 228 | 0.030 |
Why?
| | Disasters | 1 | 2016 | 101 | 0.030 |
Why?
| | Patient Education as Topic | 1 | 2020 | 770 | 0.030 |
Why?
| | Delayed-Action Preparations | 1 | 2015 | 192 | 0.030 |
Why?
| | Oxidation-Reduction | 1 | 2018 | 1075 | 0.030 |
Why?
| | Inactivation, Metabolic | 1 | 2014 | 9 | 0.030 |
Why?
| | Recovery of Function | 1 | 2018 | 725 | 0.030 |
Why?
| | Predictive Value of Tests | 1 | 2019 | 2113 | 0.030 |
Why?
| | Injections, Subcutaneous | 1 | 2014 | 170 | 0.030 |
Why?
| | Drug Approval | 1 | 2014 | 94 | 0.020 |
Why?
| | Eating | 1 | 2016 | 386 | 0.020 |
Why?
| | Neurons | 1 | 2023 | 1668 | 0.020 |
Why?
| | Thiazolidines | 1 | 2013 | 13 | 0.020 |
Why?
| | Pharmacokinetics | 1 | 2013 | 33 | 0.020 |
Why?
| | Indicators and Reagents | 1 | 2013 | 105 | 0.020 |
Why?
| | Species Specificity | 1 | 2014 | 543 | 0.020 |
Why?
| | Isotonic Solutions | 1 | 2013 | 43 | 0.020 |
Why?
| | Traumatology | 1 | 2012 | 33 | 0.020 |
Why?
| | Quality Control | 1 | 2012 | 163 | 0.020 |
Why?
| | Critical Care Nursing | 1 | 2013 | 48 | 0.020 |
Why?
| | Teaching | 1 | 2015 | 244 | 0.020 |
Why?
| | Qualitative Research | 1 | 2020 | 1734 | 0.020 |
Why?
| | Socioeconomic Factors | 1 | 2017 | 1327 | 0.020 |
Why?
| | Organizational Innovation | 1 | 2012 | 124 | 0.020 |
Why?
| | Infusions, Intra-Arterial | 1 | 2012 | 61 | 0.020 |
Why?
| | Arginine | 1 | 2013 | 264 | 0.020 |
Why?
| | Educational Measurement | 1 | 2015 | 331 | 0.020 |
Why?
| | Arterial Pressure | 1 | 2012 | 130 | 0.020 |
Why?
| | United States Food and Drug Administration | 1 | 2012 | 208 | 0.020 |
Why?
| | Case-Control Studies | 1 | 2019 | 3647 | 0.020 |
Why?
| | Acute Coronary Syndrome | 1 | 2014 | 299 | 0.020 |
Why?
| | Erythrocytes | 1 | 2016 | 750 | 0.020 |
Why?
| | Drug Monitoring | 1 | 2014 | 399 | 0.020 |
Why?
| | Explosive Agents | 1 | 2009 | 7 | 0.020 |
Why?
| | Fingers | 1 | 2010 | 106 | 0.020 |
Why?
| | Injections | 1 | 2010 | 201 | 0.020 |
Why?
| | Delphi Technique | 1 | 2011 | 350 | 0.020 |
Why?
| | Inflammation | 1 | 2020 | 2919 | 0.020 |
Why?
| | Thrombosis | 1 | 2013 | 398 | 0.020 |
Why?
| | Vasodilator Agents | 1 | 2010 | 326 | 0.020 |
Why?
| | Comorbidity | 1 | 2013 | 1665 | 0.020 |
Why?
| | Pulse | 1 | 2006 | 30 | 0.020 |
Why?
| | Immunoassay | 1 | 2007 | 108 | 0.020 |
Why?
| | Coronary Circulation | 1 | 2006 | 134 | 0.010 |
Why?
| | Early Diagnosis | 1 | 2007 | 251 | 0.010 |
Why?
| | Electric Countershock | 1 | 2006 | 126 | 0.010 |
Why?
| | Delivery of Health Care | 1 | 2012 | 947 | 0.010 |
Why?
| | Haplorhini | 1 | 2005 | 51 | 0.010 |
Why?
| | Postoperative Complications | 1 | 2013 | 3034 | 0.010 |
Why?
| | Magnetic Resonance Imaging | 1 | 2012 | 3926 | 0.010 |
Why?
|
|
Bebarta's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors  People in Profiles who have published with this person. _
Similar People  People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors  People whose addresses are nearby this person. _
|